Publications by authors named "Jennifer Richer"

Claim this Profile
A
Androgen Receptors Promote Oxidative Phosphorylation and Resistance to Palmitate Lipotoxicity in ER-Mutant Breast Cancer.
Dane T Sessions, Dillon P Boulton, Nicole S Spoelstra, M Cecilia Caino, Min Yu, Jennifer K Richer

Endocrinology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastasis-associated wound repair promotes reciprocal activation of the lung epithelium and breast cancer metastases during outgrowth.
Jessica L Christenson, Nicole S Spoelstra, Michelle M Williams, Kathleen I O'Neill, David J Orlicky, Jennifer K Richer

bioRxiv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Buenos Aires Breast Cancer Symposium 2024: bridging basic and clinical research in breast cancer.
Martín Abba, Fariba Behbod, Paolo Ceppi, Roger Chammas, Robert Clarke, Jennifer Richer

Medicina (B Aires)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EYA3 regulation of NF-κB and CCL2 suppresses cytotoxic NK cells in the premetastatic niche to promote TNBC metastasis.
Sheera R Rosenbaum, Connor J Hughes, Kaiah M Fields, Stephen Connor Purdy, Annika L Gustafson, Jennifer Richer

Sci Adv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Spatial Structure of the Tumor Immune Microenvironment Can Explain and Predict Patient Response in High-Grade Serous Carcinoma.
Lucy B Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian Rickert, Jennifer K Richer

Cancer Immunol Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blocking Tryptophan Catabolism Reduces Triple-Negative Breast Cancer Invasive Capacity.
Li-Wei Kuo, Lyndsey S Crump, Kathleen O'Neill, Michelle M Williams, Jessica L Christenson, Jennifer K Richer

Cancer Res Commun· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and immune responses to neoadjuvant fulvestrant with or without enzalutamide in ER+/Her2- breast cancer.
Anthony D Elias, Alyse W Staley, Monica Fornier, Gregory A Vidal, Vida Alami, Jennifer K Richer

NPJ Breast Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Tryptophan Catabolism in Ovarian Cancer to Attenuate Macrophage Infiltration and PD-L1 Expression.
Lyndsey S Crump, Jessica L Floyd, Li-Wei Kuo, Miriam D Post, Mike Bickerdike, Jennifer K Richer

Cancer Res Commun· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironment.
Toru Hanamura, Kozue Yokoyama, Shigehisa Kitano, Hiroshi Kagamu, Makiko Yamashita, Jennifer K Richer

Cancer Immunol Immunother· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spatial structure of the tumor immune microenvironment can explain and predict patient response in high-grade serous carcinoma.
Lucy Van Kleunen, Mansooreh Ahmadian, Miriam D Post, Rebecca J Wolsky, Christian Rickert, Jennifer K Richer

bioRxiv· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Union of Basic and Clinical Pharmacology CXIII: Nuclear Receptor Superfamily-Update 2023.
Thomas P Burris, Ian Mitchelle S de Vera, Isabelle Cote, Colin A Flaveny, Udayanga S Wanninayake, Jennifer K Richer

Pharmacol Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-Omics.
Lisa Welter, Serena Zheng, Sonia Maryam Setayesh, Michael Morikado, Arushi Agrawal, Jennifer K Richer

Cancers (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II trial of fulvestrant plus enzalutamide in ER+/HER2- advanced breast cancer.
Anthony D Elias, Nicole S Spoelstra, Alyse W Staley, Sharon Sams, Lyndsey S Crump, Jennifer K Richer

NPJ Breast Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling collective cell behavior in cancer: Perspectives from an interdisciplinary conversation.
Frederick R Adler, Alexander R A Anderson, Abhinav Bhushan, Paul Bogdan, Jose Javier Bravo-Cordero, Jennifer K Richer

Cell Syst· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RUNX1 Is Regulated by Androgen Receptor to Promote Cancer Stem Markers and Chemotherapy Resistance in Triple Negative Breast Cancer.
Natalia B Fernández, Sofía M Sosa, Justin T Roberts, María S Recouvreux, Luciana Rocha-Viegas, Jennifer K Richer

Cells· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The underappreciated role of resident epithelial cell populations in metastatic progression: contributions of the lung alveolar epithelium.
Jessica L Christenson, Michelle M Williams, Jennifer K Richer

Am J Physiol Cell Physiol· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancers co-opt normal mechanisms of tolerance to promote immune evasion and metastasis.
Lyndsey S Crump, Kelsey T Kines, Jennifer K Richer, Traci R Lyons

Am J Physiol Cell Physiol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single N6-methyladenosine site regulates lncRNA HOTAIR function in breast cancer cells.
Allison M Porman, Justin T Roberts, Emily D Duncan, Madeline L Chrupcala, Ariel A Levine, Jennifer K Richer

PLoS Biol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antigens Expressed by Breast Cancer Cells Undergoing EMT Stimulate Cytotoxic CD8 T Cell Immunity.
Faye A Camp, Tonya M Brunetti, Michelle M Williams, Jessica L Christenson, Varsha Sreekanth, Jennifer K Richer

Cancers (Basel)· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Revealing Molecular Mechanisms Supporting Trophoblast-Mediated Maternal Immune Tolerance.
Michelle M Williams, Jennifer K Richer

Endocrinology· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer.
Kathleen I O'Neill, Li-Wei Kuo, Michelle M Williams, Hanne Lind, Lyndsey S Crump, Jennifer K Richer

Cancers (Basel)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer.
Zheqi Li, Nicole S Spoelstra, Matthew J Sikora, Sharon B Sams, Anthony Elias, Jennifer K Richer

NPJ Breast Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
Zheqi Li, Yang Wu, Megan E Yates, Nilgun Tasdemir, Amir Bahreini, Jennifer K Richer

Cancer Res· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.
Zheqi Li, Olivia McGinn, Yang Wu, Amir Bahreini, Nolan M Priedigkeit, Jennifer K Richer

Nat Commun· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways.
Michelle M Williams, Sabrina A Hafeez, Jessica L Christenson, Kathleen I O'Neill, Nia G Hammond, Jennifer K Richer

Pharmaceuticals (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis